Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Leuk Lymphoma. 2013 Aug 28;55(5):979–987. doi: 10.3109/10428194.2013.828348

Table 5.

Decision making in elderly AML based on expected outcomes

Induction
Mortality
CR Rate 3-year Survival Conventional
Chemotherapy
< 15% > 40% > 15% YES
> 30% < 20% < 10% NO*
15-30% 20-40% > 10% ?**
*

Clinical trials of novel, investigational agents recommended

**

Clinical trials comparing standard regimens to new strategies recommended CR = complete remission